Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
2016;39(suppl 1):S52-S59
Here's what the research says about how the two medications compare, when making the switch makes sense, and what to expect if you do
For patients experiencing non-emergent back pain during GLP-1-based therapy, a systematic approach to management can often provide relief while allowing continuation of beneficial metabolic treatment
Clinicians should monitor patients for potential adverse effects including pancreatitis (severe, persistent abdominal pain), gallbladder disease (right upper quadrant pain), diabetic retinopathy complications (especially with rapid glucose improvement), acute kidney injury with dehydration, and hypoglycemia when combined with insulin or sulfonylureas
I think knowing that going in, while understanding the current side effects of GLP-1s, is your best tool for making a decision about the medication. Published August 2025
US$ 23.51
US$ 28.17
US$ 20.37
US$ 25.71
US$ 23.35
US$ 24.35
US$ 22.31
US$ 21.80
US$ 25.87
US$ 20.90
US$ 24.17
